Stay updated with breaking news from Accelerate Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and full year ended December 31, 2021....
The firm ended Q4 with 313 revenue-generating ID/AST instruments in the US, with another 81 instruments under contract but not yet live with customers.
Accelerate Diagnostics (NASDAQ:AXDX – Get Rating) will be issuing its quarterly earnings data after the market closes on Tuesday, March 8th. Analysts expect the company to announce earnings of ($0.30) per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link. AXDX stock opened […]
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Wednesday, March 8, 2022, at 4:30...
The firm obtained FDA breakthrough device designation for an NGS approach to identify up to 400 bacterial pathogens used to diagnose sepsis and other bacterial infections.